The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tamsulosin: an overview

På svenska

Author

Summary, in English

This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.

Publishing year

2002

Language

English

Pages

397-404

Publication/Series

World Journal of Urology

Volume

19

Issue

6

Document type

Journal article

Publisher

Springer

Topic

  • Urology and Nephrology

Keywords

  • benign prostatic hyperplasia
  • pharmacotherapy
  • alpha antagonists

Status

Published

ISBN/ISSN/Other

  • ISSN: 1433-8726